GALAPAGOS N.V. | 91.48 / -0.31% |
Date/Time | 01/25 / 08:24 |
Chg. / Chg.(%) | -0.28 / -0.31% |
Bid | 90.94 / 250 |
Ask | 91.04 / 250 |
Open | 91.48 |
Previous Close | 91.76 |
High | 91.48 |
Low | 91.48 |
Volume [EUR] | 0.00 |
Volume [Units] | 0 |
Price fixings | 1 |
ISIN | BE0003818359 |
Security | GXE |
Exchange | München |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Euronext - A.. | 91.00 | ![]() |
105,787 |
Turquoise | 90.88 | ![]() |
7,191 |
Cboe Europe .. | 91.26 | ![]() |
6,897 |
London Inter.. | 91.22 | ![]() |
5,831 |
TradeGate | 90.84 | ![]() |
339 |
Cboe Europe .. | 91.30 | ![]() |
275 |
gettex | 91.280 | ![]() |
24 |
Stuttgart | 90.920 | ![]() |
2 |
Düsseldorf | 90.88 | ![]() |
0 |
München | 91.48 | ![]() |
0 |
Berlin | 91.08 | ![]() |
0 |
Frankfurt | 90.2800 | ![]() |
0 |
Vienna Globa.. | 90.84 | ![]() |
0 |
Lang & Schwa.. | 90.80 | ![]() |
|
Xetra | 89.54 | 80 | |
Cboe Europe .. | 89.90 | 5 | |
Nasdaq Other.. | 108.0200 | 100,069 |
News
- NICE recommends Jyseleca® ▼(filgotinib) on NHS in landmark decision for rheumatoid arthritis
01/21/2021 / 08:08 - GlobeNewswire - Oxurion NV appoints Prof Alan Stitt as Chief Scientific Officer
01/20/2021 / 08:00 - GlobeNewswire - Gilead holds 25.54% of Galapagos shares
01/11/2021 / 22:01 - GlobeNewswire - OXURION to Participate in Upcoming Investor Meetings
01/07/2021 / 08:00 - GlobeNewswire - Galapagos to present at 39th Annual J.P. Morgan Healthcare Conference
01/06/2021 / 15:30 - GlobeNewswire